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The patient’s Pap smear was obtained by conven-
tional sampling. Examining Figure 1, the Pap smear di-
agnosis is:
a. Atypical squamous cells of undetermined signifi-
cance (ASCUS)
b. Atypical glandular cells of undetermined signifi-
cance (AGUS)
c. Low-grade intraepithelial lesion (LGSIL)
d. High-grade intraepithelial lesion (HGSIL)




Based on the Pap smear result, the patient is sched-
uled for colposcopy. Cervical and vaginal STD testing is






The Home Study Course is intended for the prac-
ticing colposcopist or practitioner who is seeking to develop
or enhance his or her colposcopic skills. The goal of the course
is to present colposcopic cases that are unusual or instructive
in terms of appearance, presentation, or management, or
that demonstrate new and important knowledge in the area
of colposcopy or pathology. Participants may benefit from
reading and studying the material or from testing their






The American Society for Colposcopy
and Cervical Pathology (ASCCP) is accredited by the Accredita-
tion Council for Continuing Medical Education (ACCME) to
sponsor continuing medical education for physicians. The ASCCP
designates this continuing medical education activity for 1
credit hour in Category I of the Physician’s Recognition Award
of the American Medical Association. Credit is available for
those who choose to apply. The Home Study Course is planned






Barbara S. Apgar, MD, MS
 
Department of Family Medicine, University of 




A 25-year-old woman, G1P1, with normal annual
Papanicolaou (Pap) smears for the past 6 years, presents
for evaluation because of post-coital bleeding of one-
month duration. She has been using oral contraceptive









application of 5% acetic acid. Your colposcopic impres-
sion (Fig. 2) is most consistent with a diagnosis of:
a. Squamous metaplasia
b. Low-grade cervical intraepithelial neoplasia (CIN1)
c. High-grade cervical intraepithelial neoplasia (CIN2-3)
d. Squamous cell carcinoma




You obtain a cervical biopsy and perform an en-
docervical curettage (ECC). Results of the colposcopi-
cally directed biopsy (Fig. 3) of the lesion depicted at 12
o’clock in Figure 2 are most consistent with:
a. Squamous metaplasia
b. Low-grade cervical intraepithelial neoplasia (CIN1)
c. High-grade cervical intraepithelial neoplasia (CIN3)
d. Adenocarcinoma in situ




The histologic findings from the ECC reveal (Fig. 4):
a. Normal endocervical epithelium
b. Microglandular hyperplasia
c. Adenocarcinoma in situ
d. Adenocarcinoma




Based on the cytologic findings and histologic results
of the cervical biopsy and the ECC, the next step in
management of this patient is:
a. Discuss the results with the pathologist
b. Repeat cytology in 4 to 6 months






Figure 5 is a section of the surgical specimen after
surgery. Your diagnosis is:
a. CIN3



















Cytology reveals atypical glandular cells of undeter-
mined significance (AGUS). The cytology report did
not specify a subclassification of “favor reactive or
neoplastic” diagnosis. According to the Bethesda Sys-
tem, AGUS Pap smears are defined as glandular cells
with nuclear atypia “that exceeds obvious reactive or
reparative changes but lacks unequivocal features of
invasive adenocarcinoma.” In this smear, the cells ex-
hibit nuclei that are irregular and enlarged, but there
is no prominent hyperchromasia, decrease in cyto-
plasm, or nuclear crowding. The cytological diagno-
sis would be more likely to favor a reactive process. It
has been shown that AGUS smears are more likely to
be confirmed histologically as preinvasive or invasive






Colposcopy reveals a dense, aceto-white lesion that
appears to override the columnar epithelium. The le-
sion is completely visible on the transformation zone,
is contiguous with the squamocolumnar junction,
and does not extend into the endocervical canal. The
lesion is so dense it appears raised and the border
with the normal columnar epithelium is very sharp.
The lesion retained the aceto-whiteness for an ex-
tended period of time. There is no evidence of abnor-
mal or atypical vessels. The lesion extends peripherally
at 12 o’clock towards the native squamous epithe-
lium. The dense, aceto-white epithelium is not consis-
tent with squamous metaplasia, although the lesion
extends over the columnar epithelium. The colpo-
scopic impression would include suspicion for adeno-
carcinoma in situ (AIS), which has been described as
fused villi overriding the columnar epithelium (often
seen as discrete patches of various sizes) and resem-
bling an immature transformation zone. Atypical ves-
sel patterns are common in AIS lesions. Because the
lesion is contiguous with the SCJ, vessels are absent
and the lesion is not divided into discrete patches,





The histology of the lesion depicted in Figure 2 is
consistent with CIN3. The nuclei of the basaloid cells
are large and hyperchromatic and the cytoplasm is
scant. The abnormal cells occupy the full thickness of
the squamous epithelium. There are no cells in this
histologic sample that represent invasive squamous





The histologic diagnosis of the endocervical sample is
microglandular hyperplasia, a response to progester-
one stimulation. Microglandular hyperplasia lacks
significant nuclear atypia, and few, if any, mitotic fig-
ures are usually present. Microglandular hyperplasia,
as opposed to adenocarcinoma in situ, is character-





Based on the diagnosis of CIN3 and an ECC that is
consistent with microglandular hyperplasia, a discus-
sion with the pathologist should occur. The cytology
and histology should be compared to ensure that the
source of the atypical glandular cells has been identi-
fied. The cytologic diagnosis of AGUS may be ex-
plained by the presence of microglandular hyperpla-
sia. Asking the pathologist to review the original
cytologic sample is prudent before a decision is made
about treatment. A diagnosis of AGUS, adenocarci-
noma cannot be ruled out, occurs in about 10% of
women who are subsequently shown to have histo-
logic microglandular hyperplasia. The decision in this
case is whether the squamous lesion can be treated
with a simple excisional procedure or whether a
conization should be performed because of suspected
glandular disease. It is doubtful there is squamous









copy is satisfactory. Given the cytologic diagnosis,
the presence of an endocervical glandular lesion is
possible, and the pathology should be reviewed prior





Because the cytologic diagnosis is explained by the
presence of microglandular hyperplasia and the ECC
did not reveal preinvasive or invasive glandular dis-
ease, a simple electrosurgical excision could be per-
formed. Additionally, some colposcopists would elect
to perform endometrial sampling prior to definitive
treatment because of the complaint of post-coital
bleeding and AGUS diagnosis even if the cytology did
not favor neoplasia. In this case, endometrial histol-
ogy was normal. The surgical diagnosis was CIN3
and margins were clean. Repeat ECC at the time of
the excision revealed microglandular hyperplasia
without evidence of a more serious abnormality. A
cold-knife conization is not necessary because the pa-
thologist felt that the atypical glandular cells were
consistent with microglandular hyperplasia and the
ECC showed no markedly atypical cells. A hysterec-
tomy is clearly not indicated because of the absence





1. Dinh TV, Haque M, Gracia JM et al. Papanicolaou
smears of atypical glandular cells of undetermined significance:
Histological correlations and suggestions for management. 
 
J
Lower Genit Tract Dis
 
 1999;3(2):73–76.
2. Wright VC. Colposcopy of adenocarcinoma in situ and
adenocarcinoma of the uterine cervix: Differentiation from other
cervical lesions. 
 
J Lower Genit Tract Dis
 
 1999;3(2):83–97.
3. Cox JT. ASCCP practice guidelines: Management of
glandular abnormalities in the cervical smear. 
 
J Lower Genit
Tract Dis
 
 1997;1:41–45.
